|
19/11/2024
|
07:00
|
Finalisation of commercial agreement with Croda
|
RNS
|
|
25/10/2024
|
16:29
|
Holding(s) in Company
|
RNS
|
|
23/10/2024
|
14:40
|
Integration update and share price movement
|
RNS
|
|
17/10/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
16/10/2024
|
07:00
|
Issue of Equity and Total Voting Rights
|
RNS
|
|
11/10/2024
|
07:00
|
Acquisition and Financial Update
|
RNS
|
|
04/10/2024
|
14:02
|
Notice of Investor Meet Company Presentation
|
RNS
|
|
19/09/2024
|
07:00
|
Final testing of SkinBiotix by Croda completed
|
RNS
|
|
13/08/2024
|
12:49
|
Holding(s) in Company
|
RNS
|
|
08/08/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
02/08/2024
|
07:00
|
Investment of £1.56m from new investors
|
RNS
|
|
29/07/2024
|
07:00
|
Full year trading update
|
RNS
|
|
29/07/2024
|
07:01
|
Appointment of Senior Croda VP as Board Advisor
|
RNS
|
|
23/07/2024
|
07:00
|
Closure of Convertible Bond Facility
|
RNS
|
|
22/07/2024
|
07:00
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
15/07/2024
|
07:00
|
Notice of Business Update & Investor Presentation
|
RNS
|
|
28/06/2024
|
15:16
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
18/06/2024
|
07:00
|
AxisBiotix Acne study reports positive data
|
RNS
|
|
29/05/2024
|
07:00
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
11/04/2024
|
11:44
|
Holding(s) in Company
|
RNS
|
|
05/04/2024
|
07:00
|
Conversion Notice & Total Voting Rights
|
RNS
|
|
22/03/2024
|
07:00
|
Half-year Report
|
RNS
|
|
18/03/2024
|
11:36
|
Holding(s) in Company
|
RNS
|
|
18/03/2024
|
07:00
|
New research project and CSO to return to academia
|
RNS
|
|
12/03/2024
|
07:00
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
08/03/2024
|
09:43
|
Notice of Results
|
RNS
|
|
28/02/2024
|
12:41
|
Conversion notice and alternative financing
|
RNS
|
|
27/02/2024
|
07:00
|
Positive Interim AxisBiotix Acne study results
|
RNS
|
|
20/02/2024
|
07:00
|
Dermatonics to launch Once Heel Balm in AMEA
|
RNS
|
|
09/02/2024
|
07:00
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
06/02/2024
|
07:31
|
Dermatonics Full Year trading update
|
RNS
|
|
26/01/2024
|
07:00
|
Completion of Acquisition of Dermatonics
|
RNS
|
|
25/01/2024
|
07:00
|
Acquisition of Dermatonics
|
RNS
|
|
25/01/2024
|
07:00
|
£5.0m Convertible Bond Facility & First Drawdown
|
RNS
|
|
29/12/2023
|
10:49
|
Result of AGM
|
RNS
|
|
29/12/2023
|
08:13
|
Update on transaction timelines to early 2024
|
RNS
|
|
06/12/2023
|
07:00
|
Notice of AGM and posting of Annual Report
|
RNS
|
|
30/11/2023
|
17:25
|
Final Results
|
RNS
|
|
30/11/2023
|
07:00
|
AxisBiotix-Psâ„¢ to launch on Amazon UK
|
RNS
|
|
24/11/2023
|
07:00
|
Holding(s) in Company
|
RNS
|
|
23/11/2023
|
15:37
|
Holding(s) in Company
|
RNS
|
|
22/11/2023
|
07:00
|
Update regarding Nominated Adviser and Broker
|
RNS
|
|
21/11/2023
|
07:00
|
Result of Retail Offer
|
RNS
|
|
17/11/2023
|
07:00
|
Result of Placing
|
RNS
|
|
16/11/2023
|
16:35
|
Retail Offer
|
RNS
|
|
16/11/2023
|
16:33
|
Placing and Retail Offer
|
RNS
|
|
25/10/2023
|
07:25
|
Acne study, Trading and Auditor updates
|
RNS
|
|
19/10/2023
|
07:00
|
Extension of Croda contract for SkinBiotixâ„¢
|
RNS
|
|
15/09/2023
|
09:00
|
health authority approval for AxisBiotix in France
|
RNS
|
|
05/09/2023
|
07:00
|
Update on acne programme
|
RNS
|